Document Detail


Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed a high-fat diet.
MedLine Citation:
PMID:  22420611     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This study aimed to evaluate the effects of rosuvastatin (ST) and rosiglitazone (GZ) on insulin resistance (IR) and on liver as well as adipose tissue in mice fed a high-fat (HF) diet. Our data show that treatment with rosuvastatin resulted in a marked improvement in insulin sensitivity characterised by enhanced glucose clearance during insulin tolerance test and a 70% decrease in the HOMA-IR index level (P=0.0008). The rosuvastatin-treated mice exhibited lower gains in body mass (-8%; P<0.01) and visceral fat pad thickness (-60%; P<0.01) compared with the untreated HF group. In comparison with HF mice, HF+ST-treated mice showed a significant reduction in hepatomegaly and liver steatosis (-6%; P<0.05 and -21%; P<0.01, respectively). In HF+ST-treated mice, the hepatic triglyceride levels were reduced by 58% compared with the HF group (P <0.01). In addition, the expression of SREBP1 (sterol regulatory element-binding protein) was decreased by 50% in the livers of HF+ST-treated mice (P<0.01) relative to the HF mice. The levels of resistin were lower in the HF+ST-treated group compared with the HF group (44% less, P< 0.01). In conclusion, we demonstrated that rosuvastatin treatment improved insulin sensitivity and decreased liver steatosis in mice fed a high-fat diet. Furthermore, rosuvastatin reduced body mass gains, improved the circulating levels of plasma cholesterol and triglycerides, and reduced hepatic triglycerides, which was concomitant with lower resistin.
Authors:
Julio Cesar Fraulob; Vanessa Souza-Mello; Marcia Barbosa Aguila; Carlos A Mandarim-de-Lacerda
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-15
Journal Detail:
Title:  Clinical science (London, England : 1979)     Volume:  -     ISSN:  1470-8736     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7905731     Medline TA:  Clin Sci (Lond)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cryopreservation of human testicular diploid germ cell suspensions.
Next Document:  Modeling trade-off between PAH toxicity reduction and negative effects of sorbent amendments to cont...